ZyStor Therapeutics - Ownership and Business Overview

Life ScienceCompany

ZyStor Therapeutics Ownership

Who owns ZyStor Therapeutics?


Was ZyStor Therapeutics formerly PE-backed?

Yes. ZyStor Therapeutics was formerly owned by 1 private investor.

ZyStor Therapeutics Business Overview

Where is ZyStor Therapeutics headquartered?

ZyStor Therapeutics is headquartered in Milwaukee, Wisconsin.

What sector is ZyStor Therapeutics in?

ZyStor Therapeutics is a life science company.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

ZyStor Therapeutics, Inc.

10437 Innovation Drive Suite 100,
Milwaukee, Wisconsin 53226-4838
United States,
(414) 727-9777

ZyStor Therapeutics, Inc. is a biotechnology company developing innovative therapeutics that will significantly improve the lives of patients who suffer from genetic disorders known as lysosomal storage diseases (LSDs). ZyStor employs a novel, proprietary technology which improves the delivery of therapeutics that replace the missing lysosomal enzyme in LSD patients. ZyStor has demonstrated in cell culture and in a well-characterized animal model that this technology provides several distinct advantages over other LSD therapeutics in use today.

 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.